The American Association for Cancer Research’s annual conference featured updates from several companies on key candidates ...

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene ...

WuXi Biologics soared 5.12 percent and Galaxy Entertainment and New World Development were unchanged. The lead from Wall Street is upbeat as the major averages opened higher and improved as the ...

Theriva Biologics, Inc, a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States. The company’s lead product ...

WuXi Biologics stood out among these companies with an "A-" score for leadership on climate change. Committed to the Science Based Target initiative (SBTi), WuXi Biologics has adopted an ...

Firm commitment to tackling climate change in support of United Nations Sustainable Development Goals Earth Day 2025 - Our Power, Our Planet, Contribute to a sustainable future SHANGHAI, April 22, ...

Morningstar brands and products Company Portfolio ...

SHANGHAI, April 22, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been ...

SHANGHAI, April 22, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been ...